THROMBOPHLEBITIS MIGRANS

THROMBOPHLEBITIS MIGRANS was reported 340 times

THROMBOPHLEBITIS MIGRANS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Claudin 18.2-directed Cytolytic Antibody [EPC] 8 0.0052
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 129 0.0013
2 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 8 0.0013
3 Programmed Death Ligand-1 Blocker [EPC] 23 0.0011
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 5 0.0006
5 Endoglycosidase [EPC] 1 0.0005
6 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
7 CTLA-4-directed Blocking Antibody [EPC] 19 0.0004
8 Platinum-based Drug [EPC] 101 0.0004
9 Amyloid Beta-directed Antibody [EPC] 1 0.0003
10 Microtubule Inhibitor [EPC] 42 0.0003
11 Osmotic Diuretic [EPC] 1 0.0002
12 Vascular Endothelial Growth Factor Inhibitor [EPC] 34 0.0002
13 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
14 Epidermal Growth Factor Receptor Antagonist [EPC] 7 0.0001
15 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 3 0.0001
16 Stimulant Laxative [EPC] 2 0.0001
17 Factor Xa Inhibitor [EPC] 35 0.0001
18 Cephalosporin Antibacterial [EPC] 1 0.0001
19 Antifibrinolytic Agent [EPC] 1 0.0001
20 Provitamin D2 Compound [EPC] 3 0.0001
21 Antimalarial [EPC] 1 0.0001
22 Nucleoside Metabolic Inhibitor [EPC] 26 0.0001
23 Antiprotozoal [EPC] 1 0.0001
24 Kinase Inhibitor [EPC] 49 0.0001
25 Bile Acid [EPC] 2 0.0001
26 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
27 Influenza A M2 Protein Inhibitor [EPC] 1 0.0001
28 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
29 Androgen Receptor Inhibitor [EPC] 4 0.0001
30 Orexin Receptor Antagonist [EPC] 1 0.0001
31 Topoisomerase Inhibitor [EPC] 4 0.0001
32 Estrogen Receptor Antagonist [EPC] 2 0.0000
33 Aldosterone Antagonist [EPC] 6 0.0000
34 Aromatase Inhibitor [EPC] 4 0.0000
35 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
36 Dihydropyridine Calcium Channel Blocker [EPC] 9 0.0000
37 Proton Pump Inhibitor [EPC] 16 0.0000
38 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
39 Interleukin-17A Antagonist [EPC] 1 0.0000
40 Alkylating Drug [EPC] 6 0.0000
41 Nucleoside Analog Antiviral [EPC] 2 0.0000
42 Integrin Receptor Antagonist [EPC] 2 0.0000
43 Protease Inhibitor [EPC] 1 0.0000
44 Prostaglandin Analog [EPC] 2 0.0000
45 Leukocyte Growth Factor [EPC] 3 0.0000
46 RANK Ligand Inhibitor [EPC] 4 0.0000
47 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
48 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
49 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
50 Xanthine Oxidase Inhibitor [EPC] 3 0.0000
51 Methylxanthine [EPC] 1 0.0000
52 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
53 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
54 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
55 BCL-2 Inhibitor [EPC] 1 0.0000
56 Nonsteroidal Anti-inflammatory Drug [EPC] 18 0.0000
57 HER2/neu Receptor Antagonist [EPC] 1 0.0000
58 Azole Antifungal [EPC] 2 0.0000
59 Catecholamine [EPC] 1 0.0000
60 Corticosteroid [EPC] 15 0.0000
61 Central Nervous System Stimulant [EPC] 1 0.0000
62 Nitrate Vasodilator [EPC] 1 0.0000
63 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
64 Platelet Aggregation Inhibitor [EPC] 6 0.0000
65 Osmotic Laxative [EPC] 3 0.0000
66 Expectorant [EPC] 2 0.0000
67 Angiotensin 2 Receptor Blocker [EPC] 3 0.0000
68 Mood Stabilizer [EPC] 2 0.0000
69 Loop Diuretic [EPC] 4 0.0000
70 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
71 Opioid Agonist [EPC] 2 0.0000
72 Benzodiazepine [EPC] 5 0.0000
73 Vitamin C [EPC] 3 0.0000
74 alpha-Adrenergic Blocker [EPC] 1 0.0000
75 Calcium [EPC] 1 0.0000
76 Janus Kinase Inhibitor [EPC] 1 0.0000
77 Vitamin B12 [EPC] 2 0.0000
78 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
79 Atypical Antipsychotic [EPC] 2 0.0000
80 Vitamin D [EPC] 1 0.0000
81 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
82 Insulin Analog [EPC] 1 0.0000
83 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
84 Thalidomide Analog [EPC] 1 0.0000